Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer. | Int J Environ Res Public Health | 2018 | 30042310 | PubTator, text mining | PubMed |
| Cytotoxic and N-Acetyltransferase Inhibitory Meroterpenoids from Ganoderma cochlear. | Molecules | 2018 | 30037018 | PubTator, text mining | PubMed |
| In vitro approach to elucidate the relevance of carboxylesterase 2 and N-acetyltransferase 2 to flupirtine-induced liver injury. | Biochem Pharmacol | 2018 | 30028988 | PubTator, text mining | PubMed |
| Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries. | Cancer Control | 2018 | 30027755 | PubTator, text mining | PubMed |
| Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei. | Mol Cell Proteomics | 2018 | 30021884 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma. | Radiol Oncol | 2018 | 30018519 | PubTator, text mining | PubMed |
| Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq. | Arch Toxicol | 2018 | 30008028 | PubTator, text mining | PubMed |
| NAT2 Gene Polymorphisms in Turkish Patients with Psoriasis Vulgaris. | Biomed Res Int | 2018 | 29992137 | PubTator, text mining | PubMed |
| Pharmacokinetics of Isoniazid-induced Rhabdomyolysis in a Girl. | Intern Med | 2018 | 29984757 | PubTator, text mining | PubMed |
| The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma. | Oxid Med Cell Longev | 2018 | 29977454 | PubTator, text mining | PubMed |
| Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan. | Environ Health Prev Med | 2018 | 29973138 | PubTator, text mining | PubMed |
| Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews. | J Med Genet | 2018 | 29970487 | PubTator, text mining | PubMed |
| Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity. | Mol Carcinog | 2018 | 29964355 | PubTator, text mining | PubMed |
Impact of five different medial patellofemoral ligament-reconstruction strategies and three different graft pre-tensioning states on the mean patellofemoral contact pressure: a biomechanical study on human cadaver knees. | J Exp Orthop | 2018 | 29956015 | PubTator, text mining | PubMed |
| Transcriptomics analysis reveals new insights in E171-induced molecular alterations in a mouse model of colon cancer. | Sci Rep | 2018 | 29950665 | PubTator, text mining | PubMed |
| Comparative analysis of xenobiotic metabolising N-acetyltransferases from ten non-human primates as in vitro models of human homologues. | Sci Rep | 2018 | 29950659 | PubTator, text mining | PubMed |
| A Systems-Level Analysis Reveals Circadian Regulation of Splicing in Colorectal Cancer. | EBioMedicine | 2018 | 29936137 | PubTator, text mining | PubMed |
| Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models. | Arch Toxicol | 2018 | 29916051 | PubTator, text mining | PubMed |
| Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations. | Antimicrob Agents Chemother | 2018 | 29914960 | PubTator, text mining | PubMed |
| Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. | BMC Cancer | 2018 | 29914418 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=57